SCHEDULE 14A INFORMATION

                  Proxy Statement Pursuant to Section 14(a) of
            the Securities Exchange Act of 1934 (Amendment No.    )

Filed by the Registrant /X/
Filed by a party other than the Registrant / /

Check the appropriate box:
/ /  Preliminary Proxy Statement
/ /  Confidential, for Use of the Commission Only (as permitted by Rule
     14a-6(e)(2))
/ /  Definitive Proxy Statement
/X/  Definitive Additional Materials
/ /  Soliciting Material Pursuant to Section 240.14a-12

                          Del Global Technologies Corp
- --------------------------------------------------------------------------------
                (Name of Registrant as Specified In Its Charter)

- --------------------------------------------------------------------------------
    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

/X/  No fee required.

/ /  Fee computed on table below per Exchange Act Rules 14a-6(i)(1)
     and 0-11.

    (1) Title of each class of securities to which transaction applies:

        ------------------------------------------------------------------------
    (2) Aggregate number of securities to which transaction applies:

        ------------------------------------------------------------------------
    (3) Per unit price or other underlying value of transaction computed
        pursuant to Exchange Act Rule 0-11 (set forth the amount on which the
        filing fee is calculated and state how it was determined):

        ------------------------------------------------------------------------
    (4) Proposed maximum aggregate value of transaction:

        ------------------------------------------------------------------------
    (5) Total fee paid:

        ------------------------------------------------------------------------

/ / Fee paid previously with preliminary materials.

/ / Check box if any part of the fee is offset as provided by Exchange Act Rule
    0-11(a)(2) and identify the filing for which the offsetting fee was paid
    previously. Identify the previous filing by registration statement number,
    or the Form or Schedule and the date of its filing.

    (1) Amount Previously Paid:

        ------------------------------------------------------------------------
    (2) Form, Schedule or Registration Statement No.:

        ------------------------------------------------------------------------
    (3) Filing Party:

        ------------------------------------------------------------------------
    (4) Date Filed:

        ------------------------------------------------------------------------



[LOGO] DEL GLOBAL TECHNOLOGIES CORP.


                              FOR IMMEDIATE RELEASE


              DEL MEDICAL SYSTEMS GROUP LAUNCHES NEW DIRECT DIGITAL
                                 IMAGING SYSTEM

 NEW OFFERING EXTENDS DEL'S DIGITAL PRODUCT PORTFOLIO, FIRMLY POSITIONS DEL
       WITH FULL RANGE OF COST-EFFECTIVE PRODUCTS FOR GENERAL RADIOGRAPHY


            COMPANY ALSO COMMENTS ON RAPID DEPLOYMENT OF PORTABLE X-
                        RAY SYSTEMS USED TO DIAGNOSE SARS

VALHALLA, NY, May 12, 2003 - Del Global Technologies (DGTC) ("Del") announced
today that it's Medical Systems Group, based in Franklin Park, IL and Buccinasco
(Milan), Italy, has launched a new integrated digital X-Ray solution for general
radiography applications.

"This is an important strategic development for the growth of our medical
systems business," said Samuel E. Park, President and CEO of Del Global
Technologies Corp. "This new digital capability positions us to offer a broad
selection of digital products as either new systems or upgrades to our extensive
installed base of conventional film systems."

By integrating Del's patient positioning system with an InfiMed StingRay image
acquisition and storage system and a Trixell Pixium 4600 digital flat panel
detector, the new X-Ray system offers digital image quality and is versatile
enough for virtually any general radiographic procedure. This combination
enables Del to offer its 185 independent dealers a wider choice of digital
options.

"Over the next few years, we expect a significant increase in the utilization of
digital imaging, both in the US and abroad," commented Walter F. Schneider, Del
Medical Systems Group President. "Many of our competitors are heavily invested
in a single

                      One Commerce Park, Valhalla, NY 10595
                        914-686-3600      www.delglobal.com



Del Global Technologies Corp.                                                  2
May 12, 2003

proprietary digital application, restricting them from offering more than one
digital solution. Rather than develop our own digital solution, we decided to
align with technology leaders who had already made digital investments and could
benefit from our X-Ray platform design, our system integration capabilities and
our worldwide dealer network. This strategy also accelerates our time-to-market
with new digital solutions and avoids the significant development costs being
incurred by competitors."

Del Medical currently has two digital radiographic solutions and is committed to
expanding that selection to include a wider range of low-cost offerings for
customers. The Company recently integrated a Canon Direct Radiography flat panel
sensor into a Del Medical X-Ray system for the Cleveland Regional Medical Center
in Shelby, NC.

In addition to the Company's announcement on its digital products, Del Medical
also commented on the rapid deployment of portable X-Ray units into China and
Vietnam to help authorities fight Severe Acute Respiratory Syndrome (SARS). The
equipment, manufactured by the Del Medical Systems Group in the U.S. and Italy,
is highly mobile and can be quickly deployed to regions where SARS is most
active. Many hospitals in SARS-infected areas of the world have found that a
chest examination with a portable X-Ray unit is perhaps the best modality for
imaging the disease. According to the Prince of Wales Hospital at the Chinese
University of Hong Kong, over 78% of patients diagnosed with SARS have abnormal
radiographs.

"Within the last three weeks, we have received emergency orders for over 80
portable X-Ray units for immediate delivery to China and Vietnam for early
diagnosis of SARS," said Mr. Schneider.

The use of Del's specialized mobile equipment allows doctors to detect signs of
pneumonia, which often results from the SARS disease. Importantly, this
technology helps to maintain patient isolation (provide treatment outside of
hospital buildings/specially quarantined areas) pending diagnosis, thereby
reducing the danger of transmission of the virus to others. After diagnosis, the
equipment can also be instrumental in monitoring the effects of therapeutic
treatment.



Del Global Technologies Corp.                                                  3
May 12, 2003

"We are pleased that the unique portability of our equipment and our capability
to respond quickly to the immediate demand can help expedite the detection and
treatment of SARS," added Mr. Schneider. He also commented that the same
equipment has been highly effective in field use by the US military and in
remote conditions where medical support infrastructure is very limited.

Del Global Technologies Corp. is primarily engaged in the design, manufacture
and marketing of cost-effective medical imaging and diagnostic systems
consisting of stationary and portable x-ray systems, radiographic/fluoroscopic
systems, dental imaging systems and proprietary high-voltage power conversion
subsystems for medical and other critical industrial applications. Industrial
applications for which Del supplies power subsystems include airport explosives
detection, analytical instrumentation, semiconductor capital equipment and
energy exploration.

Statements about future results made in this release may constitute
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. These statements are based on current
expectations and the current economic environment. The Company cautions that
these statements are not guarantees of future performance. They involve a number
of risks and uncertainties that are difficult to predict including, but not
limited to, the ability of the Company to implement its business plan,
management changes, changing industry and competitive conditions, obtaining
anticipated operating efficiencies, securing necessary capital facilities,
favorable determinations in various legal and regulatory matters and favorable
general economic conditions. Actual results could differ materially from those
expressed or implied in the forward-looking statements. Important assumptions
and other important factors that could cause actual results to differ materially
from those in the forward-looking statements are specified in the Company's
filings with the Securities and Exchange Commission.

Del Global filed with the Securities and Exchange Commission a definitive proxy
statement relating to the solicitation of proxies with respect to the Del Global
2003 Annual Meeting of Shareholders. Del Global will file with the Commission,
and may file other proxy solicitation materials. Investors and security holders
are urged to read the



Del Global Technologies Corp.                                                  4
May 12, 2003

proxy statement and any other proxy solicitation materials (when they become
available) because they will contain important information. Del Global and the
Directors and certain of the executive officers of Del Global may be deemed to
be participants in the solicitation of proxies in respect of electing the Board
of Directors of Del Global at the 2003 Annual Meeting of Shareholders.
Additional information with respect to the beneficial ownership of those
executive officers and Directors of Del Global common stock is set forth in the
definitive proxy statement filed by Del Global with the Commission. Investors
and security holders may obtain a free copy of the preliminary proxy statement
and other documents filed by Del Global with the Commission at the Commission's
website at http://www.sec.gov. You may also access a copy of Del Global's
definitive proxy statement by accessing http://www.delglobal.com. In addition,
you may obtain a free copy of the definitive proxy statement by contacting
Georgeson Shareholder Communications, Inc. toll free at (800) 545-1782 (banks
and brokers call collect at (212) 440-9800).

CONTACTS:

DEL GLOBAL TECHNOLOGIES CORP.

Samuel E. Park, President and Chief Executive Officer
Thomas V. Gilboy, Chief Financial Officer
(914) 686-3600

MEDIA

The Abernathy MacGregor Group, Inc.
Steve Frankel
(212) 371-5999

INVESTORS

Georgeson Shareholder Communications Inc.
(800) 545-1782